Generic Peptides
In addition, CPC specializes in the production of generic peptides on an industrial scale, following the CGMP’s (Current Good Manufacturing Practices). Our expertise allows us to manufacture a range of high-quality generic peptides at a commercial scale. With stringent quality control measures in place, we ensure consistent and reliable production of generic peptides that meet regulatory standards.
Our Generic API Portfolio:
Disease Area
API
Indication
DMF Status
Tumour
Prostate & Breast Cancer;
Endometriosis; Uterine Leiomyomata;
Precocious Puberty
MFDS: 20200625-210-J-661
NMPA: Y20190007496(A)
TFDA: 110DMF050097
Prostate & Breast Cancer;
Endometriosis; Uterine Leiomyomata;
Assisted Reproduction
NMPA: Y20170001090(A)
Suppress production of the sex hormones
NMPA: Y20230000413
Endometriosis; Uterine Fibroids;
Premature Puberty; Prostate Cancer; ART.
NMPA：2024 Q2
Procreation
In Vitro Fertilization (IVF)
NMPA: Y20190001147(A)FDA: 034884
Diabetes
Exenatide is an injectable diabetes medicine
that helps control blood sugar levels.
This medication helps pancreas produce
insulin more efficiently
NMPA: 2015/12
NMPA: Y20170001378
Type ll diabetes
DMF： 2024 Q1
NMPA： 2024 Q1
Tirzepatide
Type ll diabetes
Early R&D
Gastrointetinal
An analogue of vasopressin, prescribed for
bleeding esophageal varices, septic shock,
hepatorenal syndrome and in management of
low blood pressure
NMPA:Y20200000281(A)
CEP : 2020-111
ASMF: The Nethelands (03883)
ASMF: Germany (4388)
EDQM: R0-CEP 2020-111
lrritable Bowel Syndrome with Constipation (IBS-C):
Chronic Idiopathic Constipation (CIC)
NMPA：Y20210000906
A prescription medicine for adults with Short Bowel Syndrome
who need additional nutrition or fluids fromIV feeding
DMF：2024 Q4
Immunoloy
Treatment of moderate-to-severe pruritus associated with
chronic kidney disease(CKD-aP; uremic pruritus)
in adults undergoing hemodialysis
NMPA：2025 Q1
